Cargando…

Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition

Tumor treating fields (TTFields) are approved for glioblastoma (GBM) therapy. TTFields disrupt cell division by inhibiting spindle fiber formation. Spindle assembly checkpoint (SAC) inhibition combined with antimitotic drugs synergistically decreases glioma cell growth in cell culture and mice. We h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kessler, Almuth F., Frömbling, Greta E., Gross, Franziska, Hahn, Mirja, Dzokou, Wilfrid, Ernestus, Ralf-Ingo, Löhr, Mario, Hagemann, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125382/ https://www.ncbi.nlm.nih.gov/pubmed/30210815 http://dx.doi.org/10.1038/s41420-018-0079-9

Ejemplares similares

Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields)
por: Nickl, Vera, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier
por: Salvador, Ellaine, et al.
Publicado: (2023)

Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood–Brain Barrier In Vitro and In Vivo
por: Salvador, Ellaine, et al.
Publicado: (2022)

Changes of O(6)-Methylguanine DNA Methyltransferase (MGMT) Promoter Methylation in Glioblastoma Relapse—A Meta-Analysis Type Literature Review
por: Feldheim, Jonas, et al.
Publicado: (2019)

Long-term tumor control of spinal dissemination of cerebellar glioblastoma multiforme by combined adjuvant bevacizumab antibody therapy: a case report
por: Linsenmann, Thomas, et al.
Publicado: (2014)

Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients
por: Feldheim, Jonas, et al.
Publicado: (2018)

Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response
por: Hagemann, Carsten, et al.
Publicado: (2019)

Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma Patients
por: Kessler, Almuth F., et al.
Publicado: (2020)

Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
por: Feldheim, Jonas, et al.
Publicado: (2022)

Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma
por: Nickl, Vera, et al.
Publicado: (2023)

Expression-analysis of the human endogenous retrovirus HERV-K in human astrocytic tumors
por: Kessler, Almuth Friederike, et al.
Publicado: (2014)

Ribosomal Protein S27/Metallopanstimulin-1 (RPS27) in Glioma—A New Disease Biomarker?
por: Feldheim, Jonas, et al.
Publicado: (2020)

CXCR4: A new player in vestibular schwannoma pathogenesis
por: Breun, Maria, et al.
Publicado: (2018)

Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
por: Vergote, Ignace, et al.
Publicado: (2023)

BRMS1 in Gliomas—An Expression Analysis
por: Feldheim, Jonas, et al.
Publicado: (2023)

Primary brain amyloidoma, both a neoplastic and a neurodegenerative disease: a case report
por: Löhr, Mario, et al.
Publicado: (2019)

TTFields Prolonged the PFS of Epithelioid Glioblastoma Patient: A Case Report
por: Ding, Yuxuan, et al.
Publicado: (2023)

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma
por: Lapa, Constantin, et al.
Publicado: (2016)

Alternating Electric Fields (TTFields) Activate Ca(v)1.2 Channels in Human Glioblastoma Cells
por: Neuhaus, Eric, et al.
Publicado: (2019)

Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures
por: Hagemann, Carsten, et al.
Publicado: (2010)

[(68)Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas
por: Breun, Maria, et al.
Publicado: (2019)

First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis
por: Kassubek, Rebecca, et al.
Publicado: (2022)

The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
por: Oberheim-Bush, Nancy Ann, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines
por: Fishman, Hila, et al.
Publicado: (2023)

Analysis of ADAM9 regulation and function in vestibular schwannoma primary cells
por: Nattmann, Anja, et al.
Publicado: (2020)

Case Report: A Case Series Using Natural Anatomical Gaps—Posterior Cervical Approach to Skull Base and Upper Craniocervical Meningiomas Without Bone Removal
por: Lilla, Nadine, et al.
Publicado: (2021)

Evaluating the therapeutic effect of tumor treating fields (TTFields) by monitoring the impedance across TTFields electrode arrays
por: Li, Xing, et al.
Publicado: (2022)

Tumor growth under rhGM-CSF application in an orthotopic rodent glioma model
por: Linsenmann, Thomas, et al.
Publicado: (2019)

Dexamethasone and compliance affect TTFields efficacy to glioblastoma patients: a systematic review and meta-analysis
por: Li, Shupeng, et al.
Publicado: (2022)

High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T(reg) depletion
por: Löhr, Mario, et al.
Publicado: (2018)

ADAM9: A novel player in vestibular schwannoma pathogenesis
por: Breun, Maria, et al.
Publicado: (2020)

Basis of catalytic assembly of the mitotic checkpoint complex
por: Faesen, Alex C., et al.
Publicado: (2017)

Primary Spinal Glioblastoma Multiforme with Secondary Manifestation as a Cerebral “Angioglioma.” Literature Review and Case Report
por: Linsenmann, Thomas, et al.
Publicado: (2015)

An Overview of Sub-Cellular Mechanisms Involved in the Action of TTFields
por: Tuszynski, Jack A., et al.
Publicado: (2016)

Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas – a planning study
por: Straube, Christoph, et al.
Publicado: (2018)

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
por: Bokstein, Felix, et al.
Publicado: (2020)

Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis
por: Ballo, Matthew T., et al.
Publicado: (2023)

Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness
por: Breun, Maria, et al.
Publicado: (2023)

Mitotic checkpoints, MUGs and kinetochores
por: Brinkley, Bill R.
Publicado: (2013)

Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment
por: Lee, Yeon-Joo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1tgampu200qlfsoogvrkh8qfpo